NIH-funded research NIH-funded research

How brain support cells shape daily blood pressure rhythms

Official title: The Role of Astrocytes in Circadian Control of Blood Pressure in the Nucleus of the Solitary Tract

Funded at Rowan University · NIH-11290796 · Data updated 2026-11-12

This project looks at how astrocytes, a type of brain support cell, help control daily blood pressure patterns that may go awry in people with disrupted sleep schedules like shift workers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRowan University
NIH-funded
Lab location1 site (Glassboro, United States)
Project startApril 15, 2024
Project endFebruary 29, 2028
Funding year2026
Award (this year)$161,000
NIH project number5R16GM153695-03
Project IDNIH-11290796 on NIH RePORTER

Who could benefit from this research

Could help

People who work rotating shifts or have chronic circadian disruption and elevated blood pressure or other cardiovascular risk factors would be the most relevant group for future human studies stemming from this work.

Less likely to help

People with normal sleep schedules and well-controlled blood pressure are unlikely to see direct benefits from this specific research in the near term.

What this research studies

This work focuses on astrocytes in a brain region called the nucleus of the solitary tract (nTS), which helps control blood pressure. Researchers will use laboratory experiments and animal models to mimic shift work and circadian misalignment and then measure how astrocyte function and glutamate transport affect nerve signals that set blood pressure across the day-night cycle. The team will study synapses in the nTS to see whether changes in astrocyte glutamate transporters alter blood pressure regulation. For people who work rotating shifts or have disrupted sleep, these findings could help explain why blood pressure and heart health worsen with circadian disruption.

Why it matters

Potential benefit: If successful, this work could reveal new biological targets to prevent or treat high blood pressure linked to shift work and circadian disruption.

How similar studies have gone: Previous human and animal studies connect circadian disruption to higher blood pressure, but targeting astrocytes in the nTS is a relatively new and mostly preclinical approach with limited prior testing.

Where this research is happening

  • Rowan University
    Glassboro, United States
    Active

Researchers

  • Principal investigator: Martinez, Diana — Rowan University
  • Study coordinator: Martinez, Diana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.